Disease | proteinuria |
Symptom | C0022658|kidney disease |
Sentences | 55 |
PubMedID- 21852669 | Whether central measures of bp or vascular stiffness are associated with increased risk of proteinuria in patients with chronic kidney disease (ckd) is unknown. |
PubMedID- 24384547 | Olmesartan is more effective than other angiotensin receptor antagonists in reducing proteinuria in patients with chronic kidney disease other than diabetic nephropathy. |
PubMedID- 23882402 | Over the years, she developed chronic kidney disease due to bence jones proteinuria, anorexia, chronic anemia (requiring multiple blood transfusions), multiple electrolyte abnormalities and herpes zoster for which she remained on prophylaxis. |
PubMedID- PMC3991017 | More importantly, spironolactone has been reported to further decrease proteinuria in patients with chronic kidney disease already on chronic treatment with ace inhibitors suggesting that aldosterone antagonists may also add to the renoprotective effect of raas inhibition in humans . |
PubMedID- 24965167 | Impact of combined losartan/hydrochlorothiazide on proteinuria in patients with chronic kidney disease and hypertension. |
PubMedID- 25880876 | Research shows that dietary interventions focused on sodium reduction lower blood pressure, decrease extracellular fluid volume and reduce proteinuria in patients with kidney disease . |
PubMedID- 23644107 | Syndrome differentiation-based treatment with traditional chinese medicine for proteinuria in patients with chronic kidney disease: a randomized multicenter trial. |
PubMedID- 20671225 | Conclusions: in chronic kidney disease patients with residual proteinuria despite combined angiotensin-converting enzyme inhibitor and angiotensin receptor blockade therapy, add-on fluvastatin does not affect urinary proteins, but further reduces serum lipids and is safe. |
PubMedID- 25788940 | However, proteinuria can occur because of other kidney diseases besides hbv-related gn (hbv-gn). |
PubMedID- 20605301 | In analyses adjusted for demographic and cardiovascular disease factors, serum albumin level, proteinuria, and cause of kidney disease, compared with quartile 4, quartile 1 was associated with a 2.22 hr (95% ci, 1.83-2.68) of kidney failure; 1.39 hr (95% ci, 1.07-1.18) of all-cause mortality; and 1.36 hr (95% ci, 1.15-1.62) of the composite outcome. |
PubMedID- 21799148 | Increasing proteinuria correlated with progression of kidney disease. |
PubMedID- 26557728 | Two previous retrospective analyses by our group suggested a role for uteroplacental flows and for two serum biomarkers, soluble fms-like tyrosine kinase 1 (sflt-1) and placental growth factor (plgf), in distinguishing between pe and chronic kidney disease (ckd) in patients with hypertension and proteinuria during pregnancy . |
PubMedID- 25018969 | Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. |
PubMedID- 24843543 | Several smaller randomized trials have indicated that paricalcitol reduces proteinuria in patients with chronic kidney disease. |
PubMedID- 22333173 | Objective: to evaluate the efficacy and safety of high-dose irbesartan in the treatment of mild and moderate proteinuria in patients with chronic kidney disease (ckd). |
PubMedID- 24646858 | Second, low salt intake may stimulate activation of the sympathetic nerve system as well as raas,22 and particularly in those with proteinuria, may be associated with progression of kidney disease. |
PubMedID- 22701173 | On one side, a low dietary protein content slows the progression of kidney disease, especially in patients with proteinuria 8. |
PubMedID- 22737779 | proteinuria among patients with chronic kidney disease: a performance measure for improving patient outcomes. |
PubMedID- 22903660 | Progressive loss of the filtration barrier allows excessive proteinuria, which ultimately leads to end-stage kidney disease (eskd). |
PubMedID- 26528285 | Supplementation with vitamin d in the general population has shown fracture prevention, suggested benefit in cardiovascular health, colorectal cancer prevention and reduction of proteinuria in patients with chronic kidney disease (20, 21). |
PubMedID- 23510329 | In diabetics and in the presence of kidney disease, especially with pathological proteinuria, renin-angiotensin-aldosterone system blockers should be preferred. |
PubMedID- 22607020 | We investigated the relationship between cys-c and proteinuria in patients with chronic kidney disease. |
PubMedID- 23167771 | We evaluated the antiproteinuric effect of pct in non-dialysis chronic kidney disease (ckd) patients with proteinuria greater than 0.5 g/24 h persisting despite anti-ras therapy titrated to minimize proteinuria in the absence of adverse effects. |
PubMedID- 23585423 | Objective: to evaluate the efficacy of enalapril treatment on decline in glomerular filtration rate and reduction in proteinuria in children with chronic kidney disease (ckd). |
PubMedID- 25412689 | We suggest that all patients at the time of hiv diagnosis should carry out a screening for kidney disease with egfr assessment, proteinuria, and urine analysis. |
PubMedID- 21365885 | Is morning urinary protein-to-creatinine ratio a reliable estimator of 24-hour proteinuria in patients with kidney diseases. |
PubMedID- 23497267 | Such studies have demonstrated associations of a resistive index to proteinuria in patients with chronic kidney disease with and without diabetes mellitus; to albuminuria and also a measure of aortic stiffness (brachial-ankle) in 150 patients with type 2 diabetes mellitus; and in patients with hypertension, a modest increase in renal resistive index was associated with a greater adjusted relative risk of albuminuria . |
PubMedID- 23552860 | We compared the therapeutic effects of fasudil on the spontaneously hypercholesterolemic (shc) rat, a model of chronic kidney disease (ckd) with proteinuria, with those of the angiotensin receptor blocker olmesartan (ol) by paying attention to the proteinuria and the macrophage phenotype. |
PubMedID- 23238659 | Objective: to examine racial/ethnic differences in the prevalence of diabetic kidney disease (dkd), with and without proteinuria, in an outpatient health care organization. |
PubMedID- 26151753 | However, the effects of statins on renal outcomes, including decline in estimated glomerular filtration rate (egfr) and proteinuria in patients with chronic kidney disease (ckd), are controversial. |
PubMedID- 23691273 | As glomerulosclerosis becomes more extensive, the gfr starts to decrease and nonselective proteinuria may result leading to chronic kidney disease and subsequently esrd . |
PubMedID- 23509710 | Lastly, the small number of studies that addressed the use of paricalcitol for the treatment of proteinuria in patients without diabetic kidney disease contain insufficient data to conclude that paricalcitol can decrease proteinuria in these conditions. |
PubMedID- 22045242 | Injury to the podocyte results in proteinuria and often leads to progressive kidney disease. |
PubMedID- 24372810 | Background: angiotensin-converting enzyme inhibitors (aceis) are currently used to control proteinuria in dogs with chronic kidney disease. |
PubMedID- 21251050 | Hepatocyte growth factor (hgf) has the therapeutic potential to improve renal fibrosis and proteinuria in rodents with chronic kidney disease. |
PubMedID- 25018979 | Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. |
PubMedID- 22934182 | proteinuria correlates with kidney disease progression and cardiovascular mortality. |
PubMedID- 23894629 | This has been proposed as a major mechanism for the progression of kidney disease in patients with proteinuria –. |
PubMedID- 24867154 | Assessment of proteinuria in patients with chronic kidney disease stage 3: albuminuria and non-albumin proteinuria. |
PubMedID- 21150213 | Whereas most chronic kidney disease patients with proteinuria would often require antiproteinuric agents, there are some exceptions. |
PubMedID- 22619886 | An open label, randomized controlled study of oral calcitriol for the treatment of proteinuria in patients with diabetic kidney disease. |
PubMedID- 21782142 | Beyond being an important diagnostic marker, proteinuria is associated with kidney disease progression in both dogs and cats: the greater the magnitude of the proteinuria, the greater the risk of renal disease progression and mortality. |
PubMedID- 26325557 | Importance: steroidal mineralocorticoid receptor antagonists, when added to a renin-angiotensin system blocker, further reduce proteinuria in patients with chronic kidney disease but may be underused because of a high risk of adverse events. |
PubMedID- 22073844 | As a pleiotropic effect, paricalcitol reduces proteinuria in patients with chronic kidney disease stages 2-4. |
PubMedID- 24052467 | Risk factors for kidney diseases and awareness of blood pressure and proteinuria in general population and in high school students: italian report for world kidney days 2012-2013. |
PubMedID- 22386936 | Statins have been shown to ameliorate renal function and reduce proteinuria in patients with chronic kidney disease. |
PubMedID- 22019331 | Background: vitamin d has shown efficacy in the reduction of proteinuria in patients with chronic kidney disease. |
PubMedID- 26587302 | His past medical history was otherwise notable for hypertension, type ii diabetes mellitus, atrial fibrillation, and chronic kidney disease with bence jones proteinuria (k-flc proteinuria of 691 mg/dl). |
PubMedID- 22917002 | By studying 189 non diabetic ckd patients, the present study clearly shows that aliskiren reduced proteinuria in patients with non-dm chronic kidney disease who were receiving arbs. |
PubMedID- 25159718 | In children with prior chronic kidney disease due to idiopathic fsgs, proteinuria should be assessed daily during the first month after transplantation to enable early diagnosis of recurrence. |
Page: 1 2